Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
Xinqiao Chu, Yaning Biao, Chengjiang Liu, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
Phurpa Wangchuk, Karma Yeshi, Alex Loukas
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 27
Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease
Karma Yeshi, Tenzin Jamtsho, Phurpa Wangchuk
Molecules (2024) Vol. 29, Iss. 16, pp. 3954-3954
Open Access | Times Cited: 6
IL23p19 therapies for moderately-to-severely active ulcerative colitis
Newaz Shubidito Ahmed, Christopher Ma
Expert Opinion on Biological Therapy (2025)
Closed Access
A clinical case of ulcerative colitis complicated by rectal stenosis in a 14-year-old child. Case report
A. M. Rimskaya, I. S. Samolygo, Yuen K. Lim, et al.
Pediatrics Consilium Medicum (2025) Vol. 1, Iss. 1, pp. 96-100
Closed Access
Identification of potential novel targets for treating inflammatory bowel disease using Mendelian randomization analysis
Ji‐Chang Fan, Yuan Lü, Jin‐Heng Gan, et al.
International Journal of Colorectal Disease (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Network Meta‐Analysis: Histologic and Histo‐Endoscopic Improvement and Remission With Advanced Therapy in Ulcerative Colitis
María Manuela Estevinho, Bernardo Sousa‐Pinto, Paula Moreira, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 10, pp. 1276-1292
Closed Access | Times Cited: 2
Treatment endpoints in ulcerative colitis: Does one size fit all?
Nikola Mitrev, Viraj C. Kariyawasam
World Journal of Gastrointestinal Pharmacology and Therapeutics (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 1
Tuberculosis risk in patients with Crohn’s disease on biologics: a retrospective analysis of the Japanese Medical Claims Database
Koji Fujimoto, Shuhei Hosomi, Y. Kobayashi, et al.
Intestinal Research (2024)
Open Access
Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-interleukins
Seung Min Hong, Won Moon
Korean Journal of Gastroenterology (2024) Vol. 84, Iss. 2, pp. 65-81
Open Access
Eficácia e segurança de terapias biológicas na retocolite ulcerativa: uma revisão integrativa da literatura
Lucas Leal Germino, Gabriella Ferreiro Salani, Ahmad Ben Moussa, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 4, pp. e72076-e72076
Open Access
Page 1

Scroll to top